Elevance Health's stock experienced a 30% decline last year, and its prospects for 2026 are uncertain. Some outlets suggest the company may face challenges, including lower revenue, earnings, and membership, while others see potential for recovery and growth. The outlook for the health insurance industry as a whole in 2026 is also mixed, with some predicting a bounce in certain areas, such as Medicare Advantage, while others are more cautious.